Literature DB >> 17892221

Induction and evasion of the type I interferon response by cytomegaloviruses.

Victor R DeFilippis1.   

Abstract

Cytomegaloviruses represent supreme pathogens in that they are capable of occupying healthy mammalian hosts for life in the face of constant antiviral immune reactions. The inability of the host to eliminate the virus likely results from numerous counteractive strategies employed to disrupt the immune response. The role of type I interferon in the antiviral response has been well documented although only recently have the pathways of induction of this powerful cytokine been described. Cytomegaloviruses have been shown to both induce and be sensitive to the effects of type I interferon. Yet these viruses also possess numerous and varied phenotypes capable of inhibiting not only interferon induction but also interferon signaling and interferon-induced antiviral processes. The balance between induction and evasion of type I interferon responses by cytomegaloviruses is discussed in this review.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17892221     DOI: 10.1007/978-0-387-71767-8_22

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  16 in total

Review 1.  Modulation of host innate and adaptive immune defenses by cytomegalovirus: timing is everything.

Authors:  A Loewendorf; C A Benedict
Journal:  J Intern Med       Date:  2010-05       Impact factor: 8.989

Review 2.  Congenital cytomegalovirus infection: molecular mechanisms mediating viral pathogenesis.

Authors:  Mark R Schleiss
Journal:  Infect Disord Drug Targets       Date:  2011-10

Review 3.  Sources and signals regulating type I interferon production: lessons learned from cytomegalovirus.

Authors:  Shilpi Verma; Chris A Benedict
Journal:  J Interferon Cytokine Res       Date:  2011-01-12       Impact factor: 2.607

4.  The cytoplasmic domain of rhesus cytomegalovirus Rh178 interrupts translation of major histocompatibility class I leader peptide-containing proteins prior to translocation.

Authors:  Rebecca Richards; Isabel Scholz; Colin Powers; William R Skach; Klaus Früh
Journal:  J Virol       Date:  2011-06-29       Impact factor: 5.103

5.  Human cytomegalovirus induces and exploits Roquin to counteract the IRF1-mediated antiviral state.

Authors:  Jaewon Song; Sanghyun Lee; Dong-Yeon Cho; Sungwon Lee; Hyewon Kim; Namhee Yu; Sanghyuk Lee; Kwangseog Ahn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-08-26       Impact factor: 11.205

Review 6.  Update on the current status of cytomegalovirus vaccines.

Authors:  Heungsup Sung; Mark R Schleiss
Journal:  Expert Rev Vaccines       Date:  2010-11       Impact factor: 5.217

7.  Physical requirements and functional consequences of complex formation between the cytomegalovirus IE1 protein and human STAT2.

Authors:  Steffen Krauss; Julia Kaps; Nathalie Czech; Christina Paulus; Michael Nevels
Journal:  J Virol       Date:  2009-10-07       Impact factor: 5.103

8.  Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ.

Authors:  Theresa Knoblach; Benedikt Grandel; Jana Seiler; Michael Nevels; Christina Paulus
Journal:  PLoS Pathog       Date:  2011-04-14       Impact factor: 6.823

9.  Regulation of PURA gene transcription by three promoters generating distinctly spliced 5-prime leaders: a novel means of fine control over tissue specificity and viral signals.

Authors:  Margaret J Wortman; Laura K Hanson; Luis Martínez-Sobrido; Ann E Campbell; Jonas A Nance; Adolfo García-Sastre; Edward M Johnson
Journal:  BMC Mol Biol       Date:  2010-11-09       Impact factor: 2.946

10.  The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses.

Authors:  Christina Paulus; Michael Nevels
Journal:  Viruses       Date:  2009-11-05       Impact factor: 5.048

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.